Harvard Psychopharmacology: A Master Class 2023

Category: VIDEO MEDICAL

Description
Reviews (0)

Harvard Psychopharmacology: A Master Class 2023

Introducing Harvard Psychopharmacology: A Master Class 2023

Discover the forefront of psychiatric treatments and delve into the fascinating world of psychopharmacology with Harvard Psychopharmacology: A Master Class 2023. This highly anticipated two-day course, now in its 13th year, is tailored for clinicians, clinical researchers, and trainees in psychiatry. Our program offers a comprehensive exploration of cutting-edge treatment strategies, focusing on challenging psychiatric cases and patients resistant to conventional therapies. By attending this course, you will gain invaluable insights into the latest advancements, emerging treatments, and the interdisciplinary nature of psychiatric care.

Why Choose Harvard Psychopharmacology: A Master Class 2023?

This unique educational experience combines in-depth lectures, interactive discussions, and expert presentations by distinguished faculty members. Our faculty consists of renowned psychiatrists and researchers who are at the forefront of their fields. They will provide practical knowledge and share their expertise on a wide range of topics, including neurobiology, treatment-resistant depression, bipolar disorder, anxiety disorders, substance abuse, sleep disorders, and much more.

Course Highlights:

Neurobiology and Brain Function: Gain a comprehensive understanding of neurotransmitter circuits, transmitters, receptors, synaptic function, and gene transcription, exploring their role in psychiatric disorders and drug treatments.
Cutting-Edge Treatments: Explore the latest advancements in the treatment of schizophrenia, bipolar disorder, depression, anxiety disorders, obsessive-compulsive disorder (OCD), borderline personality disorder, and eating disorders. Discover innovative therapies such as ketamine, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), and psychedelics.
Women’s Mental Health: Delve into the evaluation and psychopharmacological treatment of women’s mental health issues, focusing on premenstrual syndrome (PMS), perinatal and postpartum disorders, and treatment-resistant post-traumatic stress disorder (PTSD).
Substance Use Disorders: Understand the neurobiology and treatment of alcohol, cannabis, and other substance abuse disorders, gaining insights into evidence-based approaches and emerging treatments.
Geriatric Psychopharmacology: Stay up to date with the latest advances in psychopharmacology for the geriatric population, understanding the unique challenges and considerations when treating older adults.

Evaluate, Learn, and Connect:

By participating in Harvard Psychopharmacology: A Master Class 2023, you will have the opportunity to evaluate the effects of neurotransmitters and genes on psychotropic drug treatment, study the intersection between neurology and psychiatry, and explore the role of psychopharmacology in various mental health conditions. Engage in meaningful discussions, ask questions, and interact with our esteemed faculty members, fostering professional connections and expanding your network.

Promoting Emotions to Buy:

This course offers an unparalleled opportunity to enhance your clinical practice and stay at the forefront of psychiatric treatment. The knowledge and skills you gain from Harvard Psychopharmacology: A Master Class 2023 will empower you to provide optimal care for your patients, particularly those who are difficult to treat or have treatment-resistant conditions. Join us on this enlightening journey, fuel your passion for psychiatry, and become a master in the field of psychopharmacology. Don’t miss out on this extraordinary learning experience!

Enroll now and take your practice to new heights!

Who Should Attend

Psychiatrists
Researchers in Psychopharmacology and Neuroscience
Substance Abuse and Mental Health Clinicians and Researchers
Pharmacists
Nurses
Nurse Practitioners
Primary Care Physicians
Specialty Physicians
Psychologists
Physician Assistants

Learning Objectives

Upon completion of this activity, participants will be able to:

Evaluate the effects of neurotransmitters and genes on psychotropic drug treatment.
Study the interface between neurology and psychiatry.
Describe the pharmacologic treatment of schizophrenia with particular reference to the prodromal period and first episode.
Summarize the interface between medicine and psychiatric disorders with an emphasis on cardiovascular disease and cancer.
Outline the emerging theories and treatments of bipolar disorder, depression, treatment resistant depression, bipolar depression, stress and anxiety disorder.
Identify the benefits and risks of ketamine.
Discuss the role of psychotropic medications in women’s mental health with an emphasis on PMS, pregnancy, nursing and the postpartum period.
Identify emerging treatments for PTSD.
Explain the role of psychopharmacology in the treatment of substance use disorders with particular emphasis on alcohol, opiates and cannabis.
Give examples of the latest advances and problems associated with treatment approaches in the geriatric populations.
Discuss standard psychopharmacologic treatments that have now been proven to be ineffective.
Discuss the application of digital phenotype tools in the psychopharmacologic management of psychiatric disorders.

FRIDAY, APRIL 28, 2023

7:45-8:15 AM

Registration

8:15-8:30 AM

Welcome Remarks
Carl Salzman, MD

8:30-9:15 AM

Neurobiology for the Practicing Clinician: Understanding Brain Function and its Relevance to Drug Treatment in Psychiatry
Matcheri Keshavan, MD

9:15-10:00 AM

Mechanisms of Action and the Development of New Antidepressants
Alan Schatzberg, MD

10:00-10:45 AM

Psychopharmacology of Childhood and Adolescent Depression
Karen Dineen Wagner, MD, PhD

10:45-11:00 AM

Coffee Break

11:00-11:45 AM

Current Treatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities
Matcheri Keshavan, MD

11:45 AM – 12:30 PM

What You Should Really Know About the Treatment of Mania and Bipolar Depression
Roscoe Brady, MD

12:30-1:00 PM

Panel Discussion
Roscoe Brady, MD, Matcheri Keshavan, MD, Carl Salzman, MD, Alan Schatzberg, MD, Karen Dineen Wagner, MD, PhD

1:00-2:00 PM

Lunch

2:00-2:45 PM

Brain Inflammation in Neuropsychiatry
Paulo Lizano, MD

2:45-3:30 PM

Neural Circuitry Based Treatments in Psychiatry
Roscoe Brady, MD

3:30-3:45 PM

Coffee Break

3:45-4:30 PM

Decision Making in the Treatment of Resistant Psychiatric Disorders: From Blood Levels to Dosing to Treatment Combinations
Stephen Stahl, MD

4:30-5:15 PM

Panel Discussion
Roscoe Brady, MD, Paulo Lizano, MD, Stephen Stahl, MD

SATURDAY, APRIL 29, 2023

8:30-9:15 AM

Rational Use of Benzodiazepines in Anxiety Spectrum Disorders
Carl Salzman, MD

9:15-10:00 AM

Sleep in Psychiatric Disorders:
Robert Stickgold, PhD, Anthony (Tony) Cunningham, PhD

10:00-10:30 AM

Coffee Break

10:30-11:15 AM

Digital Phenotyping in Psychiatry and Psychopharmacology
John Torous, MD

11:15 AM -12:00 PM

Difficult to Treatment Patients: Borderline Personality Disorder, OCD, and Eating Disorders
Carl Salzman, MD

12:00-12:45 PM

Panel Discussion
Carl Salzman, MD, John Torous, MD, Robert Stickgold, PhD, Anthony (Tony) Cunningham, PhD

12:45-2:00 PM

Lunch

2:00-2:45 PM

Effective Treatment of Substance Use Disorders
Kevin Hill, MD

2:45-3:30 PM

The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause
Catherine Lager, MD, Marcela Almeida, MD

3:30-3:45 PM

Coffee Break

3:45-4:30 PM

Older People Are Not All the Same: Differing Approaches for Younger Old and Older Old
Carl Salzman, MD

4:30-5:15 PM

Panel Discussion
Carl Salzman, MD, Catherine Lager, MD, Marcela Almeida,MD, Kevin Hill, MD

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Harvard Psychopharmacology: A Master Class 2023